Log In needed £30 · Weight Loss Cagrilintide Excellent Quality CAS 1415456-99-3 Reliable Supplier
Report AdCagrilintide CAS 1415456-99-3
5/10/mg
Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. This drug is an investigational therapy that reduced body weight in a phase 2 trial when administered as monotherapy in participants without diabetes and with a BMI of at least 30 kg/m2 or at least 27 kg/m2 with hypertension or dyslipidaemia.
Today | Yesterday | To Date | |
---|---|---|---|
Views | |||
Browsed |